{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:45:32Z","timestamp":1791279932741,"version":"4.1.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/hjh.0b013e328311cf37","type":"journal-article","created":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T08:09:59Z","timestamp":1226045399000},"page":"2445-2449","source":"Crossref","is-referenced-by-count":49,"title":["Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women"],"prefix":"10.1097","volume":"26","author":[{"given":"Maritta K","family":"P\u00f6yh\u00f6nen-Alho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Manhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Katzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandras","family":"Kibarskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta L","family":"Antikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto U","family":"Erkkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko O","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pertti E","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto J","family":"Kaaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20210208","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9149(99)00865-6","article-title":"Evidence of a role of endogenous estrogen in the modulation of autonomic nervous system.","volume":"85","author":"Mercuro","year":"2000","journal-title":"Am J Cardiol"},{"key":"R2-26-20210208","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.jhh.1001226","article-title":"Menopause and the characteristics of the large arteries in a population study","volume":"15","author":"Staessen","year":"2001","journal-title":"J Hum Hypertens"},{"key":"R3-26-20210208","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/j.1550-8528.1998.tb00344.x","article-title":"Effects of the menopause transition on body fatness and body fat distribution","volume":"6","author":"Tchernof","year":"1998","journal-title":"Obes Res"},{"key":"R4-26-20210208","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.0001-6349.2005.00904e.x","article-title":"Menopause, energy expenditure, and body composition","volume":"84","author":"Poehlman","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R5-26-20210208","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/en.2003-0580","article-title":"Minireview: the adipocyte \u2013 at the crossroads of energy homeostasis, inflammation, and atherosclerosis","volume":"144","author":"Rajala","year":"2003","journal-title":"Endocrinology"},{"key":"R6-26-20210208","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"R8-26-20210208","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the heart outcomes prevention evaluation (HOPE) study","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"key":"R9-26-20210208","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","article-title":"Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses","volume":"321","author":"Danesh","year":"2000","journal-title":"BMJ"},{"key":"R10-26-20210208","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"R11-26-20210208","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R12-26-20210208","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1055\/s-2006-925407","article-title":"Association of serum adiponectin concentration to lipid and glucose metabolism in healthy humans","volume":"38","author":"Heliovaara","year":"2006","journal-title":"Horm Metab Res"},{"key":"R13-26-20210208","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00125-005-0089-z","article-title":"Paradoxical rise in serum adiponectin concentration in the face of acid-induced insulin resistance 13-cis-retinoic","volume":"49","author":"Koistinen","year":"2006","journal-title":"Diabetologia"},{"key":"R14-26-20210208","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.CIR.103.8.1057","article-title":"Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages","volume":"103","author":"Ouchi","year":"2001","journal-title":"Circulation"},{"key":"R15-26-20210208","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/01.CIR.0000042707.50032.19","article-title":"Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"106","author":"Okamoto","year":"2002","journal-title":"Circulation"},{"key":"R16-26-20210208","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1074\/jbc.M207198200","article-title":"Structure-function studies of the adipocyte-secreted hormone Acrp30\/adiponectin. Implications for metabolic regulation and bioactivity","volume":"278","author":"Pajvani","year":"2003","journal-title":"J Biol Chem"},{"key":"R17-26-20210208","first-page":"26","article-title":"Treatment of postmenopausal hypertension with moxonidine, a selective imidazoline receptor agonist","volume":"139","author":"Kaaja","year":"2004","journal-title":"Int J Clin Pract Suppl"},{"key":"R18-26-20210208","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"R19-26-20210208","first-page":"S29","article-title":"Moxonidine improves insulin sensitivity in insulin-resistant hypertensives","volume":"17","author":"Haenni","year":"1999","journal-title":"J Hypertens Suppl"},{"key":"R20-26-20210208","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5414\/CPP45394","article-title":"Effects of sympatholytic therapyon insulin sensitivity indices in hypertensive postmenopausal women","volume":"45","author":"Kaaja","year":"2007","journal-title":"Int J Clin Pharm Ther"},{"key":"R21-26-20210208","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/00129784-200606050-00007","article-title":"The effect of moxonidine on endothelial dysfunction in metabolic syndrome","volume":"6","author":"Topal","year":"2006","journal-title":"Am J Cardiovasc Drugs"},{"key":"R22-26-20210208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-2004-820915","article-title":"Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes","volume":"112","author":"Jacob","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R23-26-20210208","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1368-5031.2006.00951.x","article-title":"Selective imidazoline agonist moxonidine in obese hypertensive patients","volume":"60","author":"Sanjuliani","year":"2006","journal-title":"Int J Clin Pract"},{"key":"R24-26-20210208","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00004872-199715011-00002","article-title":"The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease","volume":"15","author":"Ernsberger","year":"1997","journal-title":"J Hypertens Suppl"},{"key":"R25-26-20210208","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)37935-2","article-title":"Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive koletsky rat (SHROB)","volume":"288","author":"Ernsberger","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 3","key":"R26-26-20210208","first-page":"32","article-title":"Antihyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats.","author":"Friedman","year":"1998","journal-title":"Blood Press"},{"key":"R27-26-20210208","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/01.HYP.30.6.1560","article-title":"Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats","volume":"30","author":"Henriksen","year":"1997","journal-title":"Hypertension"},{"key":"R28-26-20210208","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/bse0420105","article-title":"The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control","volume":"42","author":"Pedersen","year":"2006","journal-title":"Essays Biochem"},{"key":"R29-26-20210208","doi-asserted-by":"crossref","first-page":"RC5","DOI":"10.1007\/BF03345154","article-title":"Effect of a multidisciplinary program of weight reduction on endothelial functions in obese women.","volume":"26","author":"Nicoletti","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"R30-26-20210208","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"R31-26-20210208","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1210\/jc.2006-0299","article-title":"Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome","volume":"91","author":"Devaraj","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R32-26-20210208","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"Ferrario","year":"2006","journal-title":"Am J Cardiol"},{"key":"R33-26-20210208","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(05)70804-7","article-title":"Endothelial inflammation in insulin resistance","volume":"365","author":"Sjoholm","year":"2005","journal-title":"Lancet"},{"key":"R34-26-20210208","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) investigators: C-reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"R35-26-20210208","first-page":"384","article-title":"C-reactive protein, inflammation, and cardiovascular disease: clinical update","volume":"32","author":"Ridker","year":"2005","journal-title":"Tex Heart Inst J"},{"key":"R36-26-20210208","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2013an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"R37-26-20210208","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/01.ATV.0000029781.31325.66","article-title":"Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women","volume":"22","author":"Bermudez","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R38-26-20210208","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1258\/000456306777695735","article-title":"High sensitivity C-reactive protein and cardiovascular disease: an association built on unstable foundations?","volume":"43","author":"Sattar","year":"2006","journal-title":"Ann Clin Biochem"},{"key":"R39-26-20210208","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"R40-26-20210208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1258\/0004563021901757","article-title":"Limited clinical utility of high-sensitivity plasma C-reactive protein assays","volume":"39","author":"Campbell","year":"2002","journal-title":"Ann Clin Biochem"},{"key":"R41-26-20210208","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/aje\/kwg135","article-title":"Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA augsburg studies, 1984 and 1987","volume":"158","author":"Koenig","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R42-26-20210208","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/edrv.23.1.0456","article-title":"Changes in proinflammatory cytokine activity after menopause","volume":"23","author":"Pfeilschifter","year":"2002","journal-title":"Endocr Rev"},{"key":"R43-26-20210208","first-page":"4196","article-title":"Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo","volume":"82","author":"Mohamed-Ali","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-26-20210208","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1463-1326.2004.00463.x","article-title":"Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects","volume":"7","author":"Heliovaara","year":"2005","journal-title":"Diabetes Obesity Metab"},{"key":"R45-26-20210208","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0091-6749(95)70104-4","article-title":"Circadian characteristics of circulating interleukin-6 in men","volume":"95","author":"Sothern","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"R46-26-20210208","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"R47-26-20210208","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2006.02.010","article-title":"Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease","volume":"188","author":"Gable","year":"2006","journal-title":"Atherosclerosis"},{"key":"R48-26-20210208","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0960-9822(98)70133-2","article-title":"The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor","volume":"8","author":"Shapiro","year":"1998","journal-title":"Curr Biol"},{"key":"R49-26-20210208","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","article-title":"Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin","volume":"100","author":"Ouchi","year":"1999","journal-title":"Circulation"},{"key":"R50-26-20210208","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1172\/JCI0215736","article-title":"Selective parasympathetic innervation of subcutaneous and intra-abdominal fat \u2013 functional implications","volume":"110","author":"Kreier","year":"2002","journal-title":"J Clin Invest"},{"key":"R51-26-20210208","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/oby.2006.130","article-title":"Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice","volume":"14","author":"Imai","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"R52-26-20210208","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.amjhyper.2005.05.026","article-title":"Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension","volume":"18","author":"Nowak","year":"2005","journal-title":"Am J Hypertens"},{"key":"R53-26-20210208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ehj.2003.12.003","article-title":"Increased heart rate and reduced heart rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease","volume":"25","author":"Sajadieh","year":"2004","journal-title":"Eur Heart J"},{"key":"R54-26-20210208","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e328311cf37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T15:05:56Z","timestamp":1738508756000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200812000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328311cf37","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}